vs
Side-by-side financial comparison of Tonix Pharmaceuticals Holding Corp. (TNXP) and TECHPRECISION CORP (TPCS). Click either name above to swap in a different company.
TECHPRECISION CORP is the larger business by last-quarter revenue ($7.1M vs $5.4M, roughly 1.3× Tonix Pharmaceuticals Holding Corp.). TECHPRECISION CORP runs the higher net margin — -20.8% vs -870.3%, a 849.6% gap on every dollar of revenue. On growth, Tonix Pharmaceuticals Holding Corp. posted the faster year-over-year revenue change (108.8% vs -6.9%). TECHPRECISION CORP produced more free cash flow last quarter ($-827.0K vs $-41.5M). Over the past eight quarters, Tonix Pharmaceuticals Holding Corp.'s revenue compounded faster (47.4% CAGR vs -9.2%).
Tonix Pharmaceuticals is a pharmaceutical company based in Chatham, New Jersey that focuses on repurposed drugs for central nervous system conditions and as of 2020 was also pursuing a vaccine for COVID-19 and a biodefense project.
TechPrecision Corp is a manufacturer of custom high-precision metal fabricated components and integrated systems, serving aerospace, defense, medical technology, renewable energy, and industrial end markets primarily across North America and Europe. It specializes in producing tight-tolerance, mission-critical parts that adhere to rigorous industry quality requirements.
TNXP vs TPCS — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2026
| Metric | | |
|---|---|---|
| Revenue | $5.4M | $7.1M |
| Net Profit | $-46.9M | $-1.5M |
| Gross Margin | 80.4% | 5.4% |
| Operating Margin | -895.8% | -19.1% |
| Net Margin | -870.3% | -20.8% |
| Revenue YoY | 108.8% | -6.9% |
| Net Profit YoY | -112.2% | -84.4% |
| EPS (diluted) | $-4.28 | $-0.15 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $5.4M | $7.1M | ||
| Q3 25 | $3.3M | $9.1M | ||
| Q2 25 | $2.0M | $7.4M | ||
| Q1 25 | $2.4M | $9.5M | ||
| Q4 24 | $2.6M | $7.6M | ||
| Q3 24 | $2.8M | $8.9M | ||
| Q2 24 | $2.2M | $8.0M | ||
| Q1 24 | $2.5M | $8.6M |
| Q4 25 | $-46.9M | $-1.5M | ||
| Q3 25 | $-32.0M | $825.0K | ||
| Q2 25 | $-28.3M | $-597.0K | ||
| Q1 25 | $-16.8M | $112.0K | ||
| Q4 24 | $-22.1M | $-799.0K | ||
| Q3 24 | $-14.2M | $-601.0K | ||
| Q2 24 | $-78.8M | $-1.5M | ||
| Q1 24 | $-14.9M | $-5.1M |
| Q4 25 | 80.4% | 5.4% | ||
| Q3 25 | 58.4% | 27.1% | ||
| Q2 25 | -63.8% | 14.0% | ||
| Q1 25 | 61.2% | 22.0% | ||
| Q4 24 | 54.2% | 13.0% | ||
| Q3 24 | 44.9% | 11.3% | ||
| Q2 24 | -52.5% | 3.0% | ||
| Q1 24 | 33.1% | 14.3% |
| Q4 25 | -895.8% | -19.1% | ||
| Q3 25 | -1005.1% | 10.4% | ||
| Q2 25 | -1416.2% | -6.3% | ||
| Q1 25 | -660.9% | 3.9% | ||
| Q4 24 | -870.6% | -9.1% | ||
| Q3 24 | -551.2% | -5.5% | ||
| Q2 24 | -3501.6% | -16.8% | ||
| Q1 24 | -860.2% | -28.6% |
| Q4 25 | -870.3% | -20.8% | ||
| Q3 25 | -972.9% | 9.1% | ||
| Q2 25 | -1415.0% | -8.1% | ||
| Q1 25 | -692.8% | 1.2% | ||
| Q4 24 | -856.2% | -10.5% | ||
| Q3 24 | -503.6% | -6.7% | ||
| Q2 24 | -3567.8% | -18.3% | ||
| Q1 24 | -601.9% | -59.5% |
| Q4 25 | $-4.28 | $-0.15 | ||
| Q3 25 | $-3.59 | $0.08 | ||
| Q2 25 | $-3.86 | $-0.06 | ||
| Q1 25 | $-2.84 | $0.01 | ||
| Q4 24 | $2302.65 | $-0.08 | ||
| Q3 24 | $-22.68 | $-0.06 | ||
| Q2 24 | $-1920.85 | $-0.16 | ||
| Q1 24 | $-535.72 | $-0.59 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $207.6M | $50.0K |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $245.2M | $8.0M |
| Total Assets | $277.2M | $32.8M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $207.6M | $50.0K | ||
| Q3 25 | $190.1M | $220.0K | ||
| Q2 25 | $125.3M | $143.0K | ||
| Q1 25 | $131.7M | $195.0K | ||
| Q4 24 | $98.8M | $165.0K | ||
| Q3 24 | $28.2M | $132.0K | ||
| Q2 24 | $4.2M | $44.8K | ||
| Q1 24 | $7.0M | $138.0K |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | $3.0K | ||
| Q4 24 | $8.7M | $19.0K | ||
| Q3 24 | $9.4M | — | ||
| Q2 24 | $10.1M | — | ||
| Q1 24 | $10.8M | — |
| Q4 25 | $245.2M | $8.0M | ||
| Q3 25 | $231.1M | $9.1M | ||
| Q2 25 | $168.0M | $8.2M | ||
| Q1 25 | $180.4M | $8.7M | ||
| Q4 24 | $139.6M | $8.1M | ||
| Q3 24 | $74.2M | $8.9M | ||
| Q2 24 | $42.1M | $7.9M | ||
| Q1 24 | $108.1M | $7.8M |
| Q4 25 | $277.2M | $32.8M | ||
| Q3 25 | $252.4M | $33.8M | ||
| Q2 25 | $187.4M | $32.1M | ||
| Q1 25 | $192.9M | $33.5M | ||
| Q4 24 | $162.9M | $32.2M | ||
| Q3 24 | $95.0M | $35.0M | ||
| Q2 24 | $70.3M | $35.7M | ||
| Q1 24 | $135.3M | $34.7M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 0.00× | ||
| Q4 24 | 0.06× | 0.00× | ||
| Q3 24 | 0.13× | — | ||
| Q2 24 | 0.24× | — | ||
| Q1 24 | 0.10× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-39.6M | $183.0K |
| Free Cash FlowOCF − Capex | $-41.5M | $-827.0K |
| FCF MarginFCF / Revenue | -770.4% | -11.7% |
| Capex IntensityCapex / Revenue | 34.8% | 14.2% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-103.2M | $-4.4M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-39.6M | $183.0K | ||
| Q3 25 | $-28.8M | $-1.1M | ||
| Q2 25 | $-14.8M | $646.0K | ||
| Q1 25 | $-16.6M | $396.0K | ||
| Q4 24 | $-14.6M | $-570.0K | ||
| Q3 24 | $-18.8M | $-532.0K | ||
| Q2 24 | $-9.9M | $107.0K | ||
| Q1 24 | $-17.6M | $-452.0K |
| Q4 25 | $-41.5M | $-827.0K | ||
| Q3 25 | $-29.7M | $-2.1M | ||
| Q2 25 | $-15.4M | $-604.0K | ||
| Q1 25 | $-16.6M | $-930.0K | ||
| Q4 24 | $-14.6M | $-1.7M | ||
| Q3 24 | $-18.8M | $-2.0M | ||
| Q2 24 | — | $-94.0K | ||
| Q1 24 | $-17.7M | $-900.0K |
| Q4 25 | -770.4% | -11.7% | ||
| Q3 25 | -904.1% | -22.9% | ||
| Q2 25 | -768.8% | -8.2% | ||
| Q1 25 | -682.8% | -9.8% | ||
| Q4 24 | -566.7% | -22.9% | ||
| Q3 24 | -666.5% | -21.8% | ||
| Q2 24 | — | -1.2% | ||
| Q1 24 | -712.4% | -10.5% |
| Q4 25 | 34.8% | 14.2% | ||
| Q3 25 | 29.2% | 11.0% | ||
| Q2 25 | 26.4% | 16.9% | ||
| Q1 25 | 0.2% | 14.0% | ||
| Q4 24 | 0.1% | 15.4% | ||
| Q3 24 | 0.3% | 15.9% | ||
| Q2 24 | 0.0% | 2.5% | ||
| Q1 24 | 4.4% | 5.2% |
| Q4 25 | — | — | ||
| Q3 25 | — | -1.31× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 3.54× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
TNXP
| Zembrace Symtouch | $3.1M | 58% |
| Other | $2.3M | 42% |
TPCS
| Defense | $6.7M | 94% |
| Other | $410.0K | 6% |
